title: Hospitals with percutaneous coronary intervention capability have greater adherence to established myocardial infarction guidelines.
abstract: The American College of Cardiology/American Heart Association guidelines for acute myocardial infarction related to process of care aim to decrease morbidity and mortality and provide a standard of care for patients with acute myocardial infarction (AMI). Currently, there are limited data comparing adherence between centers providing fibrinolytic therapy alone and those that provide percutaneous coronary intervention (PCI). Reported compliance with AMI performance measures was analyzed using data from the United States Department of Health and Human Services Hospital Compare Web site from 2007, including aspirin administration, beta-blocker administration, angiotensin-converting enzyme or angiotensin receptor blocking agents, and smoking cessation counseling. Adherence to all reported measurements was significantly higher (P < 0.0001) in hospitals that reported PCI capability, compared with hospitals that reported only fibrinolytic use in AMI patients.
authors.affiliation: University of Illinois at Chicago College of Medicine, Section of Cardiology, 840 South Wood St., M/C 715, Chicago, IL 60612, USA. schopfermd@gmail.com
authors.forename: David
authors.initials: D
authors.lastname: Schopfer
authors.forename: Vikas
authors.initials: V
authors.lastname: Patel
authors.forename: Jessica
authors.initials: J
authors.lastname: Chiang
authors.forename: John
authors.initials: J
authors.lastname: Kao
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D015906:Angioplasty, Balloon, Coronary / Q000706:statistics & numerical data; D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D002309:Cardiology / Q000458:organization & administration; D003376:Counseling; D019983:Guideline Adherence / Q000458:organization & administration*; D006276:Health Facility Size / Q000706:statistics & numerical data; D006302:Health Services Research; D006801:Humans; D009203:Myocardial Infarction / Q000401:mortality / Q000628:therapy*; D010043:Outcome and Process Assessment, Health Care; D017410:Practice Guidelines as Topic; D010818:Practice Patterns, Physicians' / Q000706:statistics & numerical data; D016540:Smoking Cessation; D015912:Thrombolytic Therapy / Q000706:statistics & numerical data; D014481:United States / Q000453:epidemiology; D014483:United States Dept. of Health and Human Services
chemical_list: D000319:Adrenergic beta-Antagonists; D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D001241:Aspirin